<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C4C21A46-4769-4840-9098-B44A0423AC39"><gtr:id>C4C21A46-4769-4840-9098-B44A0423AC39</gtr:id><gtr:name>Global Lipids Genetic Consortium (GLGC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AD628B56-8DB8-4820-A581-837A7DB98F41"><gtr:id>AD628B56-8DB8-4820-A581-837A7DB98F41</gtr:id><gtr:name>ReproGen Consortium</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E94047FA-2B64-4B5E-BF12-B480D820DA31"><gtr:id>E94047FA-2B64-4B5E-BF12-B480D820DA31</gtr:id><gtr:name>Beijing Genomics Institute (BGI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C4C21A46-4769-4840-9098-B44A0423AC39"><gtr:id>C4C21A46-4769-4840-9098-B44A0423AC39</gtr:id><gtr:name>Global Lipids Genetic Consortium (GLGC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AD628B56-8DB8-4820-A581-837A7DB98F41"><gtr:id>AD628B56-8DB8-4820-A581-837A7DB98F41</gtr:id><gtr:name>ReproGen Consortium</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E94047FA-2B64-4B5E-BF12-B480D820DA31"><gtr:id>E94047FA-2B64-4B5E-BF12-B480D820DA31</gtr:id><gtr:name>Beijing Genomics Institute (BGI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/318B2157-DBD8-4366-BCF0-90E3FB15A75B"><gtr:id>318B2157-DBD8-4366-BCF0-90E3FB15A75B</gtr:id><gtr:firstName>Zhengming</gtr:firstName><gtr:surname>Chen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_14135"><gtr:id>F44CB887-A77B-4A24-A80F-F2EFF5548631</gtr:id><gtr:title>China kadoorie biobank - University of Oxford</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_14135</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>China has undergone a rapid transition in disease patterns, with chronic non-communicable diseases such as stroke, ischaemic heart disease (IHD), cancer and emphysema (COPD) accounting for most of the remaining mortality and disability. For these diseases, there are still large unexplained variations in the age specific rates between different countries and between different regions in China, indicating that important causes remain to be discovered. Heterogeneity in disease rates, non-genetic risk factors and genetic architecture, between Chinese and Western populations, and between different parts of China, helps identify new risk factors and explore known causes more comprehensively. This is particularly true for stroke, which is much less well understood in terms of genetic and non-genetic determinants than IHD.2,5,6 Stroke can be investigated particularly effectively in China, as disease rates are high and widespread use of CT/MRI allows reliable determination of stroke subtypes. Better understanding of the genetic and environmental causes of disease can lead to improvements in disease prevention, risk prediction and development of new therapies. Although retrospective case-control studies suffice for studying purely genetic factors, large bloodbased prospective studies are required for studying many non-genetic causes, and many interactions.
Genome-wide association studies (GWAS) in Caucasian have identified many disease correlates. However, some loci extend over hundreds of kilobases, involving several genes and many variants that are indistinguishable because of linkage disequilibrium (LD). Comparisons of GWAS data from the Chinese and Caucasian populations will provide opportunities to exploit local LD structure in different ethnic groups, leading to finer mapping of these known loci. 
To maximise the potential of the CKB as a comprehensive and unique biomedical research resource, we wish to undertake cohort-wide genotyping, using a custom-designed 700K SNP array (Affymetrix) optimised for Chinese populations. Newton Fund support would be used exclusively for genotyping and imputation, and will allow up to 100,000 participants to be genotyped within two years. To complete genotyping of the entire CKB cohort of 0.5 million participants, additional funding will be sought from other sources in the UK and elsewhere. Because extensive baseline information and follow-up information already exists, and planned multi-omics assays of the stored biological samples is likely to be funded from other sources, information from the proposed genotyping would create a uniquely powerful and rich resource for biomedical research over the next decade or more.</gtr:technicalSummary><gtr:fund><gtr:end>2018-03-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>5000000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Global Lipids Genetic Consortium (GLGC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Global Lipids Genetics Consortium</gtr:description><gtr:id>67E5EAD0-8D02-4DF1-A11E-724889859542</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>58c6d724eee370.72859825-1</gtr:outcomeId><gtr:partnerContribution>Access to additional GWAS data to increase the likelihood of novel significant findings.</gtr:partnerContribution><gtr:piContribution>CKB plans to share genomics data or contribute to GWAS meta analyses being conducted by this group.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Newton Fund_Cambridge</gtr:description><gtr:id>1683544B-DA3A-4D7F-8216-E9175E9307A7</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>56dffe818f67a1.72811220-1</gtr:outcomeId><gtr:partnerContribution>joint academic collaboration</gtr:partnerContribution><gtr:piContribution>The ReproGen consortium is a highly active and successful international network of investigators interested in understanding the genetic basis of reproductive ageing. We use large-scale meta-analyses of Genome-wide Association Study (GWAS) data to highlight genetic variants and genes that impact reproductive timing in humans.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>University of Oxford - OCDEM</gtr:description><gtr:id>3A89E012-A716-4083-A449-CC10283384E0</gtr:id><gtr:impact>Already contributed several novel and interesting findings including piblished research papers</gtr:impact><gtr:outcomeId>58c7cea0733ca0.91540798-1</gtr:outcomeId><gtr:partnerContribution>Provision of a post graduate research assistant working on the the identification and characterization of genetic variants that influence predisposition to type 2 diabetes and related traits.</gtr:partnerContribution><gtr:piContribution>Access to relevant CKB data including genomics data and diabetes outcome data. Paper drafting and internal genomics expertise and supervision.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Broad Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>The Genetic Investigation of ANthropometric Traits (GIANT)</gtr:department><gtr:description>GIANT: Genetic Investigation of ANthropometric Traits</gtr:description><gtr:id>0D3AF646-4EC4-4CE5-B5A7-3547D9BDD9EC</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c6d3e2f0be65.90337679-1</gtr:outcomeId><gtr:partnerContribution>Access to additional GWAS data to increase the likelihood of novel significant findings.</gtr:partnerContribution><gtr:piContribution>CKB plans to share genomics data or contribute to GWAS meta analyses being conducted by this group.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>ReproGen Consortium</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>ROHgen - (Runs of Homozygosity)</gtr:description><gtr:id>A47590A6-B685-4065-A5C4-6CF457F06194</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>58c6d4eba444c4.68468440-1</gtr:outcomeId><gtr:partnerContribution>Access to additional GWAS data to increase the likelihood of novel significant findings.</gtr:partnerContribution><gtr:piContribution>CKB plans to share genomics data or contribute to GWAS meta analyses being conducted by this group.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Health Sciences</gtr:department><gtr:description>Newton Fund_University of Leicester</gtr:description><gtr:id>2FB965F8-064B-4944-A5C0-CE30A9937661</gtr:id><gtr:impact>Nature genetic papers (in Press) &amp;quot;Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets&amp;quot;</gtr:impact><gtr:outcomeId>56dffdfe1b2c02.48300017-1</gtr:outcomeId><gtr:partnerContribution>Ongoing long-term collaboration.</gtr:partnerContribution><gtr:piContribution>CKB has included additional custom respiratory content into its array design and Prof Tobin will assist in examining this GWAs data alongside baseline and prospective datasets</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>International Stroke Genetics Consortium</gtr:department><gtr:description>International Stroke Genetics Consortium</gtr:description><gtr:id>76264C19-3EA3-4FA5-872E-3E46BD47DAE7</gtr:id><gtr:impact>In Progress</gtr:impact><gtr:outcomeId>58c6d6b6303b69.83677453-1</gtr:outcomeId><gtr:partnerContribution>Long-term collaboration. Access to additional GWAS data to increase the likelihood of novel significant findings.</gtr:partnerContribution><gtr:piContribution>CKB plans to share genomics data or contribute to GWAS meta-analyses being conducted by this group.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Beijing Genomics Institute</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Beijing Genomics Institute</gtr:description><gtr:id>8333295A-7DDF-4D76-BAC3-F12484C7DB0D</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>56dffb10bf1df9.97315042-1</gtr:outcomeId><gtr:partnerContribution>BGI are providing the facilities and technical infrastructure for the conduct of genomic assays.</gtr:partnerContribution><gtr:piContribution>CKB are working with BGI on various research projects including DNA extravtion and large-scale GWAS of 100,000 CKB samples. We are also collaboratiing with BGI's Research organisation on a Mitochondrial DNA Project. This Project will involve sequencing the mitochondrial genomes of up to 300 samples (up to 100 parent-offspring trios) from the China Kadoorie Biobank. These results can be used to assess the inheritance patterns of mitochondrial genomes, including the extent of heteroplasmy and paternal inheritance. Framework agreement for the above project and future research collaborations ( eg on Whole genome sequencing, methylation) currently being finalised.)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:description>Newton Fund_Oxford</gtr:description><gtr:id>4193A881-A5C2-4BF5-9C20-69EF0D404A32</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>56dfff036762e5.80224460-1</gtr:outcomeId><gtr:partnerContribution>joint academic collaboration</gtr:partnerContribution><gtr:piContribution>My research group is focused on the identification and characterization of genetic variants that influence predisposition to type 2 diabetes and related traits. We have led global efforts to extend these discovery efforts to ever larger, and more ethnicallydiverse samples. The collaboration we have established with you and your colleagues to study the genetics of diabetes in the China Kadoorie Biobank</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Coverage on study in Pharmaceutical industry trade journal</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>28D4DCBC-3B19-4119-9CAB-331F4A16C5D4</gtr:id><gtr:impact>Some coverage of paper on LPa2 emphasising the implications for drug target discovery and pharmaceutical inductrial practice. 

https://www.drugtargetreview.com/news/12376/prospective-biobank-studies/</gtr:impact><gtr:outcomeId>58c6d10895d4c5.01386027</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.drugtargetreview.com/news/12376/prospective-biobank-studies/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>519A3830-60A9-493B-B8EE-261E82F28A13</gtr:id><gtr:title>Type 2 Diabetes and Risk of Incident Cancers in China: A Prospective Study among 0.5 Million Chinese Adults.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7af68a4c9f3c74ddc8f8f16120b040ad"><gtr:id>7af68a4c9f3c74ddc8f8f16120b040ad</gtr:id><gtr:otherNames>Pan XF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>5aa8ec5a5b8817.37540769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8482DE7D-E221-4A8B-B6A1-A7BC992C4BF9</gtr:id><gtr:title>Effect of Hot Tea Consumption and Its Interactions With Alcohol and Tobacco Use on the Risk for Esophageal Cancer: A Population-Based Cohort Study.</gtr:title><gtr:parentPublicationTitle>Annals of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce12f6a67460924e5a7f3dba17305098"><gtr:id>ce12f6a67460924e5a7f3dba17305098</gtr:id><gtr:otherNames>Yu C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0003-4819</gtr:issn><gtr:outcomeId>5aa8ec5aa84ed0.77550798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>914086E9-EDE8-4774-A359-94DDBB31C4F7</gtr:id><gtr:title>Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ec5d8d64b82eca349c6356a4f70572"><gtr:id>c9ec5d8d64b82eca349c6356a4f70572</gtr:id><gtr:otherNames>Millwood IY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>5aa664ee829225.80253351</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_14135</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes><gtr:rcukProgramme><gtr:id>C11BDEA9-7D9D-4728-B6A9-31032921B328</gtr:id><gtr:text>Newton</gtr:text></gtr:rcukProgramme></gtr:rcukProgrammes></gtr:project></gtr:projectComposition></gtr:projectOverview>